Use of CytoSorb therapy to treat critically ill coronavirus disease 2019 patients: a case series

Use of CytoSorb therapy to treat critically ill coronavirus disease 2019 patients: a case series

Abstract Background Acute respiratory distress syndrome is an important clinical presentation of respiratory complications caused by severe acute respiratory syndrome coronavirus 2, a novel coronavirus responsible for the ongoing pandemic. The disease is poorly understood, and immunopathogenesis is...

Full description

Bibliographic Details
Main Authors: Yatin Mehta, Chitra Mehta, Saurabh Nanda, Gaurav Kochar, Joby V. George, Manish Kumar Singh
Format: Article
Language:English
Published: BMC 2021-09-01
Series:Journal of Medical Case Reports
Subjects:
CytoSorb
COVID-19
Cytokines
Intensive care unit (ICU)
Critical illness
Online Access:https://doi.org/10.1186/s13256-021-03021-y

Internet

https://doi.org/10.1186/s13256-021-03021-y

Similar Items